CRP and COVID-19: In this randomized, double-blind, placebo-controlled trial, administering cholecalciferol to patients with severe or critical COVID-19 within 24 h of ICU admission resulted in a statistically significant increase in serum 25(OH)D concentration, lymphocyte count, NK and NKT cell counts, and reduced CRP levels.